Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities

被引:119
作者
Broxmeyer, HE
Kim, CH
机构
[1] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Microbiol Immunol, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA
[4] Walther Canc Inst, Indianapolis, IN USA
关键词
chemokines; chemokine receptors; stem progenitor cells; hematopoiesis; chemotaxis;
D O I
10.1016/S0301-472X(99)00045-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The field of chemokine biology is a rapidly advancing one, with over 50 chemokines identified that mediate their effects through one or more of 16 different chemokine receptors, Chemokines, originally identified as chemotactic cytokines, manifest a number of functions, including modulation of blood cell production at the level of hematopoietic stem/progenitor cells and the directed movement of these early blood cells. This report reviews chemokines and chemokine/receptor activities mainly in the context of hematopoietic cell regulation and the numerous chemokines that manifest suppressive activity on proliferation of stem/progenitor cells. This is contrasted with the specificity of only a few chemokines for the chemotaxis of these early cells, The large number of chemokines with suppressive activity is hypothesized to reflect the different cell, tissue, and organ sites of production of these chemokines and the need to control stem/progenitor cell proliferation in different organ sites throughout the body. (C) 1999 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:1113 / 1123
页数:11
相关论文
共 149 条
  • [21] BROXMEYER HE, 1995, EXP HEMATOL, V23, P900
  • [22] Macrophage-stimulating protein, a ligand for the RON receptor protein tyrosine kinase, suppresses myeloid progenitor cell proliferation and synergizes with vascular endothelial cell growth factor and members of the chemokine family
    Broxmeyer, HE
    Cooper, S
    Li, ZH
    Lu, L
    Sarris, A
    Wang, MH
    Chang, MS
    Donner, DB
    Leonard, EJ
    [J]. ANNALS OF HEMATOLOGY, 1996, 73 (01) : 1 - 9
  • [23] BROXMEYER HE, 1999, IN PRESS J EXP MED
  • [24] MCP-1, not MIP-1α, is the endogenous chemokine that cooperates with TGF-β to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures
    Cashman, JD
    Eaves, CJ
    Sarris, AH
    Eaves, AC
    [J]. BLOOD, 1998, 92 (07) : 2338 - 2344
  • [25] Chang H C, 1989, Int Immunol, V1, P388, DOI 10.1093/intimm/1.4.388
  • [26] Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes
    Chang, MS
    McNinch, J
    Elias, C
    Manthey, CL
    Grosshans, D
    Meng, T
    Boone, T
    Andrew, DP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) : 25229 - 25237
  • [27] BIOLOGICAL AND STRUCTURAL-PROPERTIES OF MIP-1-ALPHA EXPRESSED IN YEAST
    CLEMENTS, JM
    CRAIG, S
    GEARING, AJH
    HUNTER, MG
    HEYWORTH, CM
    DEXTER, TM
    LORD, BI
    [J]. CYTOKINE, 1992, 4 (01) : 76 - 82
  • [28] Randomized phase-II study of BB-10010 (macrophage inflammatory protein-1α) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy
    Clemons, MJ
    Marshall, E
    Dürig, J
    Watanabe, K
    Howell, A
    Miles, D
    Earl, H
    Kiernan, J
    Griffiths, A
    Towlson, K
    DeTakats, P
    Testa, NG
    Dougal, M
    Hunter, MG
    Wood, LM
    Czaplewski, LG
    Millar, A
    Dexter, TM
    Lord, BI
    [J]. BLOOD, 1998, 92 (05) : 1532 - 1540
  • [29] Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
    Cole, KE
    Strick, CA
    Paradis, TJ
    Ogborne, KT
    Loetscher, M
    Gladue, RP
    Lin, W
    Boyd, JG
    Moser, B
    Wood, DE
    Sahagan, BG
    Neote, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) : 2009 - 2021
  • [30] COOPER S, 1994, EXP HEMATOL, V22, P186